Genitourinary Cancers

• Expert Video Report on Novel Immunotherapeutics
• 18th ESO ESMO Masterclass in Clinical Oncology
• ESMO Summit Latin America 2019
• Clinical session: GU cancers - Localized, castration sensitive and castration resistant prostate cancer
• Clinical session: GU cancers - Localized, castration sensitive and castration resistant prostate cancer
• Clinical Cases Presentation
• Management Prostate Cancer Latin America
• Current Standards Care Prostate Cancer
• Practice Changing Studies Prostate Cancer 2018
• ESMO Summit Africa 2019
• PROSTVAC Ineffective For Metastatic CRPC (Open access)
• ESMO E-Learning: Advances in Systemic Treatment of Advanced/Metastatic Renal Cell Carcinoma
• microRNA‐16‐5p enhances radiosensitivity through modulating Cyclin D1/E1–pRb–E2F1 pathway in prostate cancer cells
• Choline transporter-like protein 1 (CTL1/SLC44A1) is a therapeutic target molecule for prostate cancer therapy
• Safety profile and therapeutic efficacy of one cycle of [177Lu] PSMA in end stage metastatic castration resistant prostate cancer patients with low...
• Renal Cell Carcinoma: ESMO Clinical Practice Guidelines
• Expert Video Report on Renal Cell Carcinoma
• Expert Video Report on Prostate Cancer
• Practice changing studies in Bladder and Kidney Cancers in 2018
• Case Presentation in Bladder or Kidney Cancers
• Standards of Care and development of new targets in Bladder and Kidney Cancers
• Report back on workshop 3: Implementation of ESMO guidelines in Advanced Prostate Cancer – Challenges in Africa
• ESMO E-Learning: Present and Emerging Treatment Options in HER2/neu Overexpressing Metastatic Breast Cancer
• Participant Clinical Case Discussion: Metastatic Castration Resistant Prostate Cancer with Complete Response After 6 Cycles of Immunotherapy
• Advanced Urinary Cancer (Renal and Bladder)

• « Previous
• 1
• 2
• ...
• 70
• Next »